Ryman Healthcare Forecast, price target & analysts
Ryman Healthcare Target price 2026 - Analyst rating & recommendation
Ryman Healthcare Classifications & Recommendation
Ryman Healthcare Price Target
| Target Price | NZ$2.87 |
| Price | NZ$1.99 |
| Potential |
44.39%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Ryman Healthcare 2027 .
The average Ryman Healthcare target price is NZ$2.87.
This is
44.39%
register free of charge
NZ$3.68
85.14%
register free of charge
NZ$2.59
30.26%
register free of charge
|
|
| A rating was issued by 9 analysts: 7 Analysts recommend Ryman Healthcare to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Ryman Healthcare stock has an average upside potential 2027 of
44.39%
register free of charge
|
Sales and Margin forecast 2027, 2028 & 2029
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Million NZ$ | 855.59 | 936.72 |
| 12.47% | 9.48% | |
| EBITDA Margin | 9.57% | 18.21% |
| 291.07% | 90.24% | |
| Net Margin | -20.03% | 8.43% |
| 70.35% | 142.09% |
6 Analysts have issued a sales forecast Ryman Healthcare 2027 . The average Ryman Healthcare sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Ryman Healthcare EBITDA forecast 2027. The average Ryman Healthcare EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Ryman Healthcare Analysts have issued a net profit forecast 2027. The average Ryman Healthcare net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share NZ$ | -0.17 | 0.08 |
| 76.39% | 147.06% | |
| P/E | 24.95 | |
| EV/Sales | 10.39 |
5 Analysts have issued a Ryman Healthcare forecast for earnings per share. The average Ryman Healthcare EPS is
This results in the following potential growth metrics and future valuations:
Ryman Healthcare...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
